N-Acetyl-L-Cysteine Attenuates Ischemia/Reperfusion Injury-Induced Allodynia and N-Methyl-D-Aspartate Receptor Activation in Rats

BACKGROUND: Although reactive oxygen species (ROS) are believed to be involved in pathogenic mechanisms that underlie complex regional pain syndrome type I (CRPS-I), the role of ROS in the central mechanism of CRPS is not fully understood. OBJECTIVE: In this study we investigated whether ROS scavenger N-acetyl-L-cysteine (NAC) was capable of attenuating mechanical allodynia and whether pain was decreased through modulating N-methyl-D-aspartate (NMDA) receptor activation in a chronic postischemia pain (CPIP) animal model that mimics the symptoms of CRPS-I. METHODS: Thirty male Sprague-Dawley rats were randomly allocated to 5 different groups: (1) sham rats and CPIP rats treated with (2) vehicle; (3) NAC 30 mg/kg; (4) NAG 100 mg/kg; and (5) NAG 300 mg/kg intraperitoneally at 15 minutes before reperfusion. CPIP was generated after a 3-hour ischemia/reperfusion injury on the hind limb using a tight fitting O-ring. Then, mechanical paw-withdrawal thresholds to von Frey stimuli were assessed before ischemia (baseline), at 4 hours; 1, 3, and 5 days; and 1, 2, 3, and 4 weeks after reperfusion. Another set of 5 animal groups in the same categories was used to determine phosphorylated NMDA receptor 1 subunit (pNR1) immunoreactivity in the ipsilateral L4/6 spinal cord at 3 days after reperfusion. RESULTS: The sham group showed no significant difference in pain thresholds over 4 weeks. With NAG treatment, the pain thresholds measured after reperfusion increased significantly, and this increase lasted 4 weeks after reperfusion compared with the vehicle group (P < 0.01 on the ipsilateral side and P < 0.05 on the contralateral side). The relative density of pNR1 at 3 days after reperfusion in NAG-treated rats decreased significantly compared with that of the vehicle group (all, P < 0.001). The NAG dose was significantly correlated not only with paw-withdrawal threshold (p = 0.979; P < 0.001) but also with the relative density of pNR1 (p = 0.875; P < 0.001). CONCLUSIONS: NAG, administered during the pre-reperfusion period, had a long-term antiallodynic effect through the attenuation of NMDA receptor phosphor-ylation, leading to central sensitization. (Curr Ther Res Clin Exp. 2011;72:216-227) (C) 2011 Elsevier HS Journals, Inc. All rights reserved.